Preformed vascular modules designed for inosculation with host tissue

专为与宿主组织接种而设计的预制血管模块

基本信息

  • 批准号:
    8480588
  • 负责人:
  • 金额:
    $ 35.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-01 至 2017-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Rapid restoration of blood flow is vital to restoring tissue function in many ischemic conditions, such as critical limb ischemia. A variety of strategies have been explored to solve the challenging problem of tissue vascularization, including delivery of one or more pro-angiogenic factors, the use of cell-based therapies, and the transplantation of pre-vascularized tissues. By combining some of the attractive elements of all three of these major strategies with recent advances in modular tissue engineering, this multi-PI project will create an innovative, minimally invasive approach to stimulate revascularization of ischemic tissue in vivo. Endothelial cells (EC) and mesechymal stem cells (MSC) will be encapsulated in biomaterial-based modules to allow formation of stable, pericyte-invested vascular units within these microtissues over time in culture. Inosculation of vessels in adjacent microtissues will be assessed and a candidate mechanism by which neighboring sprouts form anastomoses will be tested. Underlying this mechanism is the hypothesis that inosculation depends in part on cell-generated and matrix- propagated tractional forces between neighboring vascular sprouts. Our overall strategy is to perform vascularized modules in vitro that rapidly inosculate with each other and with host vessels, and thereby restore blood perfusion to an ischemic tissue following delivery in vivo. This strategy will be evaluated by completing three Specific Aims. In Aim 1, we will characterize and quantify the ability of EC and MSC encapsulated within modular biomaterials to develop into primitive vessel-like networks. Aim 2 will focus on the interactions of these prevascularized modules, assessing their ability to inosculate in a model tissue in vitro, and will test a candidate mechanism explaining how nascent capillaries interconnect. In Aim 3, we will compare the therapeutic efficacy of our approach head-to-head with two other cell-based strategies in an established model of hind limb ischemia. Successful completion of these three aims may lead to a new and powerful technique to rapidly restore vascular beds in virtually any ischemic tissue, and thereby offers the potential to broadly impact current clinical approaches to treating peripheral arterial disease, coronary artery disease, and complications due to diabetes. These studies will also improve current understanding of the synergistic roles of EC, MSC, and their microenvironment on capillary morphogenesis, which in turn may lead to important new discoveries that can enhance tissue vascularization strategies.
描述(由申请人提供):在许多缺血情况下,快速恢复血流对于恢复组织功能至关重要,例如严重的肢体缺血。人们探索了多种策略来解决组织血管化这一具有挑战性的问题,包括输送一种或多种促血管生成因子,使用基于细胞的治疗方法,以及移植血管前组织。通过将所有这三种主要策略的一些吸引人的元素与模块化组织工程的最新进展相结合,这一多PI项目将创造一种创新的、微创的方法来刺激体内缺血组织的血管重建。内皮细胞(EC)和间充质干细胞(MSC)将被包裹在基于生物材料的模块中,以允许随着培养时间的推移在这些微组织中形成稳定的周细胞投资的血管单位。将评估相邻微组织中的血管融合,并测试相邻芽形成吻合的候选机制。这种机制背后的假设是,融合部分依赖于细胞产生的和基质传播的相邻维管束之间的牵引力。我们的总体策略是在体外进行血管化的模块,这些模块彼此之间以及与宿主血管快速融合,从而在体内交付后恢复对缺血组织的血液灌流。这一战略将通过完成三个具体目标进行评估。在目标1中,我们将表征和量化包裹在模块化生物材料中的EC和MSC发展成原始血管样网络的能力。目标2将专注于这些预血管模块的相互作用,评估它们在体外与模型组织融合的能力,并将测试解释新生毛细血管如何相互连接的候选机制。在目标3中,我们将在已建立的后肢缺血模型中,将我们的方法与其他两种基于细胞的策略的治疗效果进行比较。这三个目标的成功实现可能会导致一种新的、强大的技术,在几乎任何缺血组织中快速恢复血管床,从而提供 广泛影响目前治疗外周动脉疾病、冠状动脉疾病和糖尿病并发症的临床方法。这些研究还将提高目前对EC、MSC及其微环境在毛细血管形态发生中的协同作用的理解,这反过来可能导致重要的新发现,可以加强组织血管形成的策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew J Putnam其他文献

for alphavbeta metastatic melanoma invasion
用于αvβ转移性黑色素瘤侵袭
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Andrew J Putnam;Veronique V. Schulz;Eric M Freiter;H. Bill;C. Miranti
  • 通讯作者:
    C. Miranti

Andrew J Putnam的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrew J Putnam', 18)}}的其他基金

2023 Biomaterials and Tissue Engineering
2023 生物材料与组织工程
  • 批准号:
    10675948
  • 财政年份:
    2023
  • 资助金额:
    $ 35.93万
  • 项目类别:
Preformed vascular modules designed for inosculation with host tissue
专为与宿主组织接种而设计的预制血管模块
  • 批准号:
    8712550
  • 财政年份:
    2013
  • 资助金额:
    $ 35.93万
  • 项目类别:
Preformed vascular modules designed for inosculation with host tissue
专为与宿主组织接种而设计的预制血管模块
  • 批准号:
    9130229
  • 财政年份:
    2013
  • 资助金额:
    $ 35.93万
  • 项目类别:
THE ROLE OF ECM MECHANICS IN REGULATING CAPILLARY MORPHOGENESIS
ECM 力学在调节毛细血管形态发生中的作用
  • 批准号:
    8362719
  • 财政年份:
    2011
  • 资助金额:
    $ 35.93万
  • 项目类别:
ACTIN-MEDIATED CONTRACTILITY EFFECTS ON CAPILLARY MORPHOGENESIS IN TISSUES
肌动蛋白介导的组织毛细血管形态发生的收缩效应
  • 批准号:
    8365751
  • 财政年份:
    2011
  • 资助金额:
    $ 35.93万
  • 项目类别:
THE ROLE OF ECM MECHANICS IN REGULATING CAPILLARY MORPHOGENESIS
ECM 力学在调节毛细血管形态发生中的作用
  • 批准号:
    8362700
  • 财政年份:
    2011
  • 资助金额:
    $ 35.93万
  • 项目类别:
An Artificial Perivascular Niche for Mesenchymal Stem Cells
间充质干细胞的人工血管周围生态位
  • 批准号:
    8030582
  • 财政年份:
    2011
  • 资助金额:
    $ 35.93万
  • 项目类别:
An Artificial Perivascular Niche for Mesenchymal Stem Cells
间充质干细胞的人工血管周围生态位
  • 批准号:
    8225140
  • 财政年份:
    2011
  • 资助金额:
    $ 35.93万
  • 项目类别:
ACTIN-MEDIATED CONTRACTILITY EFFECTS ON CAPILLARY MORPHOGENESIS IN TISSUES
肌动蛋白介导的组织毛细血管形态发生的收缩效应
  • 批准号:
    8170960
  • 财政年份:
    2010
  • 资助金额:
    $ 35.93万
  • 项目类别:
THE ROLE OF ECM MECHANICS IN REGULATING CAPILLARY MORPHOGENESIS
ECM 力学在调节毛细血管形态发生中的作用
  • 批准号:
    8169529
  • 财政年份:
    2010
  • 资助金额:
    $ 35.93万
  • 项目类别:

相似海外基金

How angiogenic factor induces immunosuppressive cells to tumor microenvironment
血管生成因子如何诱导免疫抑制细胞进入肿瘤微环境
  • 批准号:
    22KJ0818
  • 财政年份:
    2023
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10711027
  • 财政年份:
    2021
  • 资助金额:
    $ 35.93万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10297199
  • 财政年份:
    2021
  • 资助金额:
    $ 35.93万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10625314
  • 财政年份:
    2021
  • 资助金额:
    $ 35.93万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10405070
  • 财政年份:
    2021
  • 资助金额:
    $ 35.93万
  • 项目类别:
Physiological role of anti-angiogenic factor thrombospondin in the regulation of endometrial function during early pregnancy in cattle
抗血管生成因子血小板反应蛋白在牛妊娠早期子宫内膜功能调节中的生理作用
  • 批准号:
    20K06385
  • 财政年份:
    2020
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of lymphangiogenic regulatory mechanism of angiogenic factor CCN2 through tumor-associated macrophage
阐明血管生成因子CCN2通过肿瘤相关巨噬细胞的淋巴管生成调节机制
  • 批准号:
    17K11866
  • 财政年份:
    2017
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of vascular stabilization mechanism by anti-angiogenic factor vasohibin-1
抗血管生成因子 vasohibin-1 阐明血管稳定机制
  • 批准号:
    15K20874
  • 财政年份:
    2015
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
angiogenic therapy for cerebral infarction with anti^sense homology derived peptide targeting angiogenic factor
靶向血管生成因子的反义同源肽治疗脑梗死
  • 批准号:
    15K15523
  • 财政年份:
    2015
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The development of the anti-angiogenic factor VEGF-A165b quantification methods for cardiovascular disease.
心血管疾病抗血管生成因子 VEGF-A165b 定量方法的开发。
  • 批准号:
    26860367
  • 财政年份:
    2014
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了